Literature DB >> 23116311

A review of therapeutic effects of curcumin.

Ali Noorafshan1, Soheil Ashkani-Esfahani.   

Abstract

There is a growing interest in herbal medicine. Scientific studies have demonstrated the beneficial pharmacological effects of curcumin. Curcumin is a bright yellow spice, derived from the rhizome of Curcuma longa Linn. It has been proven that curcumin is a highly pleiotropic molecule which can be a modulator of intracellular signaling pathways that control cell growth, inflammation, and apoptosis. Curcumin might be a potential candidate for the prevention and/or treatment of some diseases due to its anti-oxidant, antiinflammatory activities and an excellent safety profile. We present an updated concise review of currently available animal and clinical studies demonstrating the therapeutic effect of curcumin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23116311

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  68 in total

1.  Cynaropicrin from Cynara scolymus L. suppresses Porphyromonas gingivalis LPS-induced production of inflammatory cytokines in human gingival fibroblasts and RANKL-induced osteoclast differentiation in RAW264.7 cells.

Authors:  Mayumi Hayata; Norihisa Watanabe; Noriaki Kamio; Muneaki Tamura; Keiko Nodomi; Kiyotaka Tanaka; Arunasiri Iddamalgoda; Hiromasa Tsuda; Yorimasa Ogata; Shuichi Sato; Kouichiro Ueda; Kenichi Imai
Journal:  J Nat Med       Date:  2018-09-14       Impact factor: 2.343

2.  Curcumin Increases HSP70 Expression in Primary Rat Cortical Neuronal Apoptosis Induced by gp120 V3 Loop Peptide.

Authors:  Chenglai Xia; Yantao Cai; Shuhua Li; Jie Yang; Guohong Xiao
Journal:  Neurochem Res       Date:  2015-08-21       Impact factor: 3.996

Review 3.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

4.  Curcumin and capsaicin modulates LPS induced expression of COX-2, IL-6 and TGF-β in human peripheral blood mononuclear cells.

Authors:  Thriveni Vasanthkumar; Manjunatha Hanumanthappa; Rangaswamy Lakshminarayana
Journal:  Cytotechnology       Date:  2019-09-05       Impact factor: 2.058

5.  Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention.

Authors:  Justin A Colacino; Sean P McDermott; Maureen A Sartor; Max S Wicha; Laura S Rozek
Journal:  Breast Cancer Res Treat       Date:  2016-06-15       Impact factor: 4.872

6.  Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death.

Authors:  Kirtikar Shukla; Himangshu Sonowal; Ashish Saxena; Kota V Ramana
Journal:  Biochem Pharmacol       Date:  2018-03-14       Impact factor: 5.858

7.  Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.

Authors:  Jin Ma; Shi-Yu Ma; Chun-Hua Ding
Journal:  Chin J Integr Med       Date:  2016-03-08       Impact factor: 1.978

8.  Piperine Augments the Protective Effect of Curcumin Against Lipopolysaccharide-Induced Neurobehavioral and Neurochemical Deficits in Mice.

Authors:  Ashok Jangra; Mohit Kwatra; Tavleen Singh; Rajat Pant; Pawan Kushwah; Yogita Sharma; Babita Saroha; Ashok Kumar Datusalia; Babul Kumar Bezbaruah
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

9.  Curcumin inhibits proliferation of interleukin-22-treated HaCaT cells.

Authors:  Yi Zhao; Jun Sun; Wei Dou; Jin-Hong Hu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Green tea extract suppresses N-methyl-N-nitrosourea-induced photoreceptor apoptosis in Sprague-Dawley rats.

Authors:  Yuko Emoto; Katsuhiko Yoshizawa; Yuichi Kinoshita; Takashi Yuri; Michiko Yuki; Kazutoshi Sayama; Nobuaki Shikata; Airo Tsubura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.